Literature DB >> 36099361

Secular Changes in Mortality and Hospitalization over Time in People with Kidney Failure or Severe CKD as Compared with Other Noncommunicable Diseases.

Marcello Tonelli1,2, Natasha Wiebe3,2, Matthew T James4,2, Scott W Klarenbach3,2, Braden J Manns4,2, Neesh Pannu3,2, Pietro Ravani4,2, Brenda R Hemmelgarn3,2.   

Abstract

BACKGROUND: Few new treatments have been developed for kidney failure or CKD in recent years, leading to perceptions of slower improvement in outcomes associated with CKD or kidney failure than for other major noncommunicable diseases.
METHODS: Our retrospective cohort study included 548,609 people with an incident noncommunicable disease, including cardiovascular diseases, diabetes, various cancers, and severe CKD or kidney failure treated with renal replacement (KF-RRT), treated in Alberta, Canada, 2004-2015. For each disease, we assessed presence or absence of 8 comorbidities; we also compared secular trends in relative (compared to a referent year of 2004) and absolute risks of mortality and mean annual days in the hospital associated with each disease after 1 year and 5 years.
RESULTS: Comorbidities increased significantly in number over time for all noncommunicable diseases except diabetes, and increased most rapidly for CKD and KF-RRT. Significant but relatively small reductions over time in the risk ratio of mortality at 1 year occurred for nearly all noncommunicable diseases. Secular trends in the absolute risk of mortality were similar; CKD and KF-RRT had a relatively favorable ranking at 1 year. Breast cancer, KF-RRT, diabetes, and colorectal cancer displayed the largest relative reductions in number of hospital days at 1 year. Significant absolute reductions in the number of hospital days were observed for both KF-RRT and CKD; the former had the highest absolute reduction among all noncommunicable diseases. Results were similar at 5 years.
CONCLUSIONS: We observed secular reductions in mortality and annual hospital days at 1 year and 5 years among incident patients with KF-RRT and severe CKD, as well as several other common noncommunicable diseases.
Copyright © 2020 by the American Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; hospitalization; mortality; renal failure

Year:  2020        PMID: 36099361      PMCID: PMC7608960          DOI: 10.1681/ASN.2020040456

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   14.978


  21 in total

Review 1.  Guidelines for the management of chronic kidney disease.

Authors:  Adeera Levin; Brenda Hemmelgarn; Bruce Culleton; Sheldon Tobe; Philip McFarlane; Marcel Ruzicka; Kevin Burns; Braden Manns; Colin White; Francoise Madore; Louise Moist; Scott Klarenbach; Brendan Barrett; Robert Foley; Kailash Jindal; Peter Senior; Neesh Pannu; Sabin Shurraw; Ayub Akbari; Adam Cohn; Martina Reslerova; Vinay Deved; David Mendelssohn; Gihad Nesrallah; Joanne Kappel; Marcello Tonelli
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

Review 2.  The ascending rank of chronic kidney disease in the global burden of disease study.

Authors:  Kitty J Jager; Simon D S Fraser
Journal:  Nephrol Dial Transplant       Date:  2017-04-01       Impact factor: 5.992

3.  The Kidney Accelerator: Innovation Wanted, Nephrologists Needed.

Authors:  Suzanne Watnick
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-25       Impact factor: 8.237

4.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

5.  Multimorbidity, dementia and health care in older people:a population-based cohort study.

Authors:  Marcello Tonelli; Natasha Wiebe; Sharon Straus; Martin Fortin; Bruce Guthrie; Matthew T James; Scott W Klarenbach; Helen Tam-Tham; Richard Lewanczuk; Braden J Manns; Hude Quan; Paul E Ronksley; Peter Sargious; Brenda Hemmelgarn
Journal:  CMAJ Open       Date:  2017-08-14

6.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

7.  Survival trends in ESRD patients compared with the general population in the United States.

Authors:  Carl van Walraven; Douglas G Manuel; Greg Knoll
Journal:  Am J Kidney Dis       Date:  2013-11-06       Impact factor: 8.860

8.  Kidney stones and kidney function loss: a cohort study.

Authors:  R Todd Alexander; Brenda R Hemmelgarn; Natasha Wiebe; Aminu Bello; Catherine Morgan; Susan Samuel; Scott W Klarenbach; Gary C Curhan; Marcello Tonelli
Journal:  BMJ       Date:  2012-08-29

9.  Methods for identifying 30 chronic conditions: application to administrative data.

Authors:  Marcello Tonelli; Natasha Wiebe; Martin Fortin; Bruce Guthrie; Brenda R Hemmelgarn; Matthew T James; Scott W Klarenbach; Richard Lewanczuk; Braden J Manns; Paul Ronksley; Peter Sargious; Sharon Straus; Hude Quan
Journal:  BMC Med Inform Decis Mak       Date:  2015-04-17       Impact factor: 2.796

10.  Overview of the Alberta Kidney Disease Network.

Authors:  Brenda R Hemmelgarn; Fiona Clement; Braden J Manns; Scott Klarenbach; Matthew T James; Pietro Ravani; Neesh Pannu; Sofia B Ahmed; Jennifer MacRae; Nairne Scott-Douglas; Kailash Jindal; Robert Quinn; Bruce F Culleton; Natasha Wiebe; Richard Krause; Laurel Thorlacius; Marcello Tonelli
Journal:  BMC Nephrol       Date:  2009-10-19       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.